Clinical Trial Update: Comparison of Biphasic Insulin Aspart Produced by the NN2000 Process to Current Process to in Type 2 Diabetes [Phase 3]

View source ↗

Summary

This Phase 3 trial update compares biphasic insulin aspart produced by the NN2000 process with the current production process in adults with Type 2 diabetes.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 2 Diabetes Mellitus

Drugs mentioned

• NovoLog Mix 70/30 (insulin aspart protamine and insulin aspart mix 70/30)

Snippet

Sponsor: Novo Nordisk A/S | Conditions: Diabetes, Diabetes Mellitus, Type 2 | Phase 3 | Status: COMPLETED